Angiotensin II (Ang II) is implicated in the development of genetic hypertension 1,2 and progression of chronic renal failure. 3 In an earlier study on kidney donors we found that nephrectomy shifts the action of Ang II from the afferent towards the efferent arteriole, 4 increasing efferent resistance and filtration pressure. Although this study revealed a shift in the site of action of Ang II, it did not analyze possible changes in sensitivity to this hormone after loss of renal tissue. Therefore, we have investigated whether nephrectomy, taken as a surrogate of renal function impairment, enhances or modifies peripheral or renal reactivity to Ang II and/or its association with common anthropological variables. To this end, we have measured blood pressure (BP) and renal vascular resistance (RVR) increases after the infusion of Ang II in 26 healthy kidney donors before and 1 year after nephrectomy. Nephrectomy did not modify the relative increase of RVR. Before nephrectomy the RVR increase after Ang II infusion was correlated with a family history of hypertension, but not with age, gender or menopausal state. After nephrectomy it was correlated with age, but not with family history of hypertension, gender or menopausal status.
Between 1995 and 2003, every potential kidney donor referred to our Unit for evaluation was asked to undergo effective renal plasma flow (ERPF) and glomerular filtration rate determination before and after infusion of exogenous Ang II (3 ng kg À1 min
À1
for 40 min), by means of the measurements of paraamino-hippurate and inulin plasma clearances before and 1 year after nephrectomy. This report concerns 26 kidney donors (all normotensive, in a sodium replete state and free from any drug treatment) who gave their consent to the protocol approved by our Ethics Committee. For the technical details of the experiment the reader is referred to our earlier work. 4 Mean arterial pressure was calculated as (2*diastolic BP þ systolic BP)/3, and renal blood flow as ERPF/1-Hematocrit. Renal vascular resistance before and after the Ang II infusion were calculated by dividing mean arterial pressure by renal blood flow, and the increase in renal resistance after Ang II (DRVR Ang II) was used as the index of renal reactivity, this increase was then multiplied by 100 to obtain the pressure increase required to maintain the same 100 ml min
of renal blood flow after Ang II infusion.
ERPF and glomerular filtration rate before nephrectomy were expressed for one kidney (assuming their even distribution between the two kidneys) to facilitate comparisons of intrarenal hemodynamics before and after nephrectomy.
A family history of hypertension was ascertained by asking the donors to report the BP values and every drug taken by their parents; if the parents were no longer alive, we asked their general practitioner about therapy. If either parent was hypertensive (BP 4140/90) or receiving antihypertensive therapy (any BP), the donor was classified as having a positive family history of hypertension. The BP values of siblings were always consistent in the classification of the family status (that is, there were no hypertensive siblings of normotensive parents or vice versa).
ANOVA, repeated measures ANOVA and regressions were calculated by means of Statview software (SAS Institute Inc., Cary, NC, USA), after having performed a Kolmogorov-Smirnov test on the continuous variables to check their consistency with a normal distribution.
Nephrectomy, as expected, determined a 40% increase in one kidney ERPF, a 59% increase in one kidney glomerular filtration rate and an 18% increase in filtration fraction. 4 One kidney ERPF decrease after Ang II was enhanced by nephrectomy in absolute, but not relative terms, whereas glomerular filtration rate, not modified by Ang II before nephrectomy, decreased both in absolute and relative values after nephrectomy, with a consequent filtration fraction decrease. Table 1 shows the data of our 26 donors before and after nephrectomy. Their age range was 27-64 years; females were more represented than males (19 vs 7; 73%) and menopausal females were more represented than premenopausal ones (11 vs 8; 58%). Family history of hypertension was present in 10/26 donors (38%). Mean arterial pressure was not affected by nephrectomy, nor was its increase affected after Ang II infusion. RVR decreased from 22.1 to 16.0 mm Hg per 100 ml min As it was apparent that the gender effect was almost entirely due to menopausal women, to avoid a confounder effect we chose to perform multiple regression analyses with gender classified as male, female and menopausal female, besides age and family history of hypertension. Table 1 also shows the results of the four multiple regression analyses with, as response variables, the increases of MBP and RVR after Ang II, taken as indexes of peripheral and renal reactivity to Ang II, respectively, and age, gender and menopause and family history of hypertension as explanatory variables. The increase of mean arterial pressure after Ang II was never significantly correlated to any of the adjusted explanatory variables either before or after nephrectomy. The increase of RVR after Ang II was directly correlated to the adjusted family history of hypertension before nephrectomy (P ¼ 0.02), but this correlation was completely lost with the removal of the kidney (P ¼ 0.93). After nephrectomy, the explanatory variables gave rise to a higher coefficient of determination (adjusted R 2 0.52 vs 0.28), and the only variable correlated with RVR increase after Ang II was the adjusted age (P ¼ 0.02), a variable not correlated before nephrectomy (P ¼ 0.40). Supplementary multiple regressions done in the female subgroup with menopausal status as an explanatory variable (not reported in the Table) gave the same results with lower levels of statistical significance (P ¼ 0.069 for hypertension family before nephrectomy and P ¼ 0.056 for age after nephrectomy). Menopause duration was not correlated to any response variable.
The pressor response to Ang II has been repeatedly found increased in older subjects; 5 it could be that the gender imbalance (female 73%) and the restricted age range (27-64 years) of our donors prevented the full appearance of this finding.
The renovascular response to Ang II has been instead described as unaffected by aging in healthy subjects, 6 whereas in essential hypertensives and normotensive subjects with a positive family history of hypertension, it has been found both increased 1, 2, 7 and decreased, 8, 9 showing that it is very unlikely that normotensive subjects with a positive family history of hypertension share the same renal hereditary hypertensive mechanism of angiotensin sensitivity.
Concerning renal failure in humans the available data are scanty; the only study we are aware of reports decreases in renal vascular reactivity, 10 suggesting differences between nephrectomized subjects and advanced renal failure patients.
In summary, our results indicate that in healthy people: (i) peripheral and renal vessels are different concerning their reactivity to Ang II and (ii) nephrectomy has qualitative, but not quantitative, effects on renal vascular reactivity to Ang II. Loss of 
